GENE ONLINE|News &
Opinion
Blog

Roche
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Reviewing the Market Trends in the Antibody-Drug Conjugate Development: A Focus on Roche, Sanofi, BMS, Seagen, and BioNTech
2024-01-05
GeneOnline’s Weekly News Highlights: Oct 22-Oct 27
2023-10-31
Roche Could Set New DLBCL Treatment Standard with First-Line Polivy Indication
2023-04-19
Roche’s Polivy Wins Support From FDA Adcom For Treating B-Cell Cancer
2023-03-10
Roche Returns Gavreto Rights To Blueprint After Ditching Collaboration
2023-02-24
Roche’s Vision Loss Drug Clocks Two Phase 3 Wins In Macular Edema
2023-02-13
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Roche’s Lunsumio Lands FDA Approval for Pretreated Follicular Lymphoma
2022-12-26
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
Roche’s Gantenerumab Fails Trials In Alzheimer’s Disease
2022-11-15
Roche Clocks Clinical Win as it Eyes Additional Vabysmo Indication
2022-10-27
Genentech Unveils Positive Two-Year Data For Spinal Muscular Atrophy Drug
2022-10-13
Roche’s Newly Approved Companion Diagnostic May Open Treatment Options for HER2-low Patients
2022-10-06
1 2 3 6
LATEST
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
$115M Series A Boosts Myricx Bio’s ADC Development with Lilly and Novo Support
2024-07-11
EVENT
Scroll to Top